With clinical data beginning to emerge, big pharma is signaling its belief that in vivo CAR generation is the next immunotherapy breakthrough.

Retinal progenitor cells (RPCs) can differentiate into all major retinal cell types during development, but they permanently lose this capacity as one grows older, leaving the adult retina with no ...

A growing body of research is challenging the long-held assumption that memory and awareness belong exclusively to the brain. Scientists working across immunology, biophysics, and neuroscience have ...

The MarketWatch News Department was not involved in the creation of this content.-- Cancer Grand Challenges awards five global teams of scientists up to $25m each to take on quest ...

This study uncovers epigenetic changes during puberty that correlate with insulin resistance, offering insights into ...

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...

In the natural world, a few extraordinary species bend this rule in surprising ways. Some can regrow entire body parts. Some ...

Read more about Nanoparticle and AI-driven vaccines target broad protection against emerging threats on Devdiscourse ...

The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the first-ever treatment built on CRISPR/Cas9 technology. That decision moved gene ...

Maternal immune activation reprograms the fetal brain, increasing alcohol-seeking behavior after adolescent exposure. Prenatal antioxidants act as a key preventive.

This valuable study provides convincing evidence that MgdE, a conserved mycobacterial nucleomodulin, downregulates inflammatory gene transcription by interacting with the histone methyltransferase ...